Home › Funds › Two Sigma Investments › NMRA
Two Sigma Investments position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)2.24M sh
Reported value held$3.82M
Portfolio Weight0.00%
First reportedQ3 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 58.50K | $825.43K | New |
| Q2 2024 | 172.52K | $1.70M | New |
| Q3 2024 | 47.60K | $628.85K | Reduce |
| Q4 2024 | 48.29K | $511.87K | Add |
| Q1 2025 | 274.31K | $274.31K | Add |
| Q2 2025 | 588.33K | $431.42K | Add |
| Q3 2025 | 299.81K | $545.66K | Reduce |
| Q4 2025 | 1.31M | $2.34M | Add |
| Q1 2026 | 2.04M | $3.97M | Add |
| Q2 2026 | 2.24M | $3.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Citadel Advisors 1.07M sh · $1.82M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026